Vitamin C
This article was originally published in The Tan Sheet
Executive Summary
Regular supplement use is associated with 40% reduced risk of noncardia gastric cancer, researchers report in October Cancer Epidemiology, Biomarkers & Prevention. Supplemental and dietary vitamin C were found to significantly lower risk of four tumor types (esophageal adenocarcinoma, gastric cardia adenocarcinoma, esophageal squamous cell carcinoma and noncardia gastric adenocarcinoma), Susan Mayne, Yale University, et al., report. Researchers find no link between multivitamins, risk of tumor type. Case-controlled study included 1,839 persons in Connecticut, New Jersey, Washington diagnosed with one of the four tumors. Subjects were asked about food consumption, supplementation patterns; research was supported by NCI grant...
You may also be interested in...
Labor/HHS approps
Senate bill passes 89-10 Nov. 6 with measure that would provide NIH Office of Dietary Supplements with up to $20 mil. to "continue and expand" ephedra safety/efficacy research, botanical research centers. HR 3061 also allocates $110 mil. to NCCAM for FY 2002; House version, which passed Oct. 11, offers $99.3 mil. for NIH center. Senate bill includes amendment by Sens. Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) providing $500,000 to cover labeling enforcement under DSHEA, language urging publication of supplement GMPs within 15 days of bill enactment (1"The Tan Sheet" Nov. 5, In Brief). Conferees, including Harkin, likely will meet week of Nov. 12 to reconcile differences...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.